Rewriting the story
of human health —
one cell at a time

Empowering biomedical innovation and a new generation of cures through precision reprogrammed human cells

Cell identity coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.

Explore our platform
bit.bio–venn_diagram–V19-Desktop bit.bio–venn_diagram–V19-Mobile

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

Learn more

ioCells™

Precision reprogrammed human iPSC-derived cells for research and drug discovery.

Discover ioCells
iocells_vial_radial_0

Latest news

bit.bio featured in Citeline by David Wild Article
bit.bio featured in Citeline by David Wild 09.05.2024
Published by Citeline
Read now
BiotechTV and Brad Loncar visit to bit.bio Article
BiotechTV and Brad Loncar visit to bit.bio 09.05.2024
Published by bit.bio
Read now
Bi/ond and bit.bio collaboration generates 3D in vitro model for studying Duchenne Muscular Dystrophy (DMD) Press Release
Bi/ond and bit.bio collaboration generates 3D in vitro model for studying Duchenne Muscular Dystrophy (DMD) 30.04.2024
Published by bit.bio
Read now
Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to lead fireside chat on programming human cells at SynBioBeta Press Release
Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to lead fireside chat on programming human cells at SynBioBeta 29.04.2024
Published by bit.bio
Read now